Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis
Infectious Disease Reports · 26.08.2024 · 16 (5) · 806-819
DOI: 10.3390/idr16050062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Disease Reports, online erschienen am 26.08.2024. Verfasst von Charlotte Birner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Critical illness causes disturbances in lipid metabolism. Here, we investigated the levels of apolipoprotein A-IV (apoA-IV), a regulator of triglyceride and cholesterol metabolism, in human sepsis. ApoA-IV (analyzed in 156 patients with systemic inflammatory response syndrome (SIRS)/sepsis) and cholesteryl ester (CE) (analyzed in 121 of these patients) were lower in patients compared to 43 healthy controls. In contrast, triglyceride (TG) levels were elevated in patients. ApoA-IV levels in plasma of the patients did not correlate with these lipids. Patients with SIRS, sepsis or septic shock had comparable apoA-IV, TG, CE and free cholesterol (FC) levels. Patients on dialysis had significantly lower CE levels, whereas apoA-IV levels did not change much. CE levels were elevated in patients with viral sepsis due to SARS-CoV-2 infection in comparison to SIRS/sepsis patients not infected by this virus. CE levels correlated negatively with procalcitonin, interleukin-6 and bilirubin, while TGs were positively associated with bilirubin and C-reactive protein. ApoA-IV, TG, CE and FC levels were not associated with bacterial infection or survival. In conclusion, this analysis suggests that CE levels decline in sepsis-related renal failure and also shows that plasma apoA-IV and CE levels are early biomarkers of sepsis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
- Institute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, 93053 Regensburg, Germany.
ORCID-Profile: Gerhard Liebisch, Marcus Höring, Stephan Schmid, Vlad Pavel, Christa Buechler
Zitieren
APA
Birner, C., Mester, P., Liebisch, G., Höring, M., Schmid, S., Müller, M., Pavel, V., & Buechler, C. (2024). Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infectious Disease Reports, 16(5), 806-819. https://doi.org/10.3390/idr16050062
Vancouver
Birner C, Mester P, Liebisch G, Höring M, Schmid S, Müller M, et al. Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infectious Disease Reports. 2024;16(5):806-819. doi:10.3390/idr16050062
BibTeX
@article{Birner2024,
author = {Birner, Charlotte and Mester, Patricia and Liebisch, Gerhard and Höring, Marcus and Schmid, Stephan and Müller, Martina and Pavel, Vlad and Buechler, Christa},
title = {Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis},
journal = {Infectious Disease Reports},
year = {2024},
volume = {16},
number = {5},
pages = {806--819},
doi = {10.3390/idr16050062}
}
EUVIMED